Search results
Showing 451 to 465 of 1308 results for social care
In development Reference number: GID-TA11819 Expected publication date: 03 September 2026
Lifileucel for previously treated unresectable or metastatic melanoma [ID3863]
In development Reference number: GID-TA10752 Expected publication date: TBC
This quality standard covers preventing further cardiovascular disease after a myocardial infarction (heart attack). It includes assessment and cardiac rehabilitation. It describes high-quality care in priority areas for improvement.
View quality statements for QS99Show all sections
Sections for QS99
- Quality statements
- Quality statement 1: Assessment of left ventricular function
- Quality statement 2: Referral for cardiac rehabilitation
- Quality statement 3: Communication with primary care
- Quality statement 4: Cardiac rehabilitation – assessment appointment
- Quality statement 5 (developmental): Options for cardiac rehabilitation
- Update information
- About this quality standard
The NICE glossary provides brief definitions and explanations of terms used on the website. The terms describe how NICE works and how its guidance is produced.
Read the biographies of our medical technologies advisory committee members.
Read the biographies of our medical technologies advisory committee members.
This indicator covers the practice can produce a register of people with moderate to severe frailty. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM185
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.
In development Reference number: GID-TA11820 Expected publication date: 14 April 2027
This interim statement outlines early value assessments, a new evidence-based approach designed to improve the care of people and effective use of NHS resources through quicker access to promising health technologies that address national unmet need
Awaiting development Reference number: GID-TA11907 Expected publication date: 10 June 2027
In development Reference number: GID-TA11636 Expected publication date: 26 August 2026
Bepirovirsen with nucleoside or nucleotide analogues for treating chronic hepatitis B [ID6608]
In development Reference number: GID-TA11803 Expected publication date: 10 March 2027
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards
This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.